Chronic lymphocytic leukemia

The most common type of chronic lymphoid leukemia. It comprises 90% of chronic lymphoid leukemias in the United States. Morphologically, the neoplastic cells are small, round B-lymphocytes. This type of leukemia is not considered to be curable with available therapy. (WHO, 2001)

Disease Alternative Name

chronic b-cell lymphocytic leukemia

chronic lymphatic leukemia

b cell lymphocytic leukemia

b-cell chronic lymphogenous leukemia

nos

chronic lymphocytic leukemia (cll)

b-cell chronic lymphoid leukemia

b cell cll

b-cell lymphocytic leukemia

b cell chronic lymphocytic leukemia

b-cell cll

cll

b-cell chronic lymphocytic leukemia

chronic lymphogenous leukemia

bcll

hematopoeitic - chronic lymphocytic leukemia (cll)

MainRecentTopDoctors

Dr. Ila Jain

Pathology

A 32-year-old woman presents to her primary care physician with a 3-week history of fever, weakness, and petechiae on her abdomen. A laboratory study shows the following results: WBC count: 125,000/mm3 Hemoglobin: 7.8% Hematocrit: 23.4...See More

11 Views

, 1 Like

, 10 Answers

LikeAnswers Share

10 Answers1 Like

Amarendra Choudhary

Ophthalmology

A 70 y/o male with a history of chronic lymphocytic leukemia referred for chronic dry eye, eye redness, blurry vision, a...See More

(Edited)

34 Views

, 8 Answers

LikeAnswers Share

8 Answers0 Like

Concluded Case

Dr. Nihal Ahmad

Unani Medicine

A 65 year old female known case of chronic lymphocytic leukemia, on chemotherapy presented with complaints of itchy scal...See More

336 Views

, 6 Likes

, 1 Answer

LikeAnswers Share

1 Answer6 Likes

Concluded answer

Dr. Nihal Ahmad

Unani Medicine

Thanks to all for your valuable response.

Dr. Saurabh Kulavi

Surgical Oncology

Concurrent Squamous Cell Carcinoma and Chronic Lymphocytic Leukemia Presenting as an Enlarging Neck Mass

1 View

, 1 Answer

LikeAnswers Share

1 Answer0 Like

Dr. Nasreen Dondapati

Hematology

B cell prolymphocytic leukemia patients differ from those with B cell chronic lymphocytic leukemia in : 1. Presenting at a younger age. 2. Having a lower total leucocyte count. 3. Having prominent lymphadenopathy. 4. Having a shorte...See More

(Edited)

7 Views

, 1 Like

, 1 Answer

LikeAnswers Share

1 Answer1 Like

Dr. Navya Pawan

Dermatology

rituximab is antiCD20 monoclonal antibody was first approved for treatment of chronic lymphocytic leukemia, now it is extensively used in Vesiculobullous disorders like pemphigus which is refractory to other treatments, there are two proto...See More

33 Views

, 3 Likes

LikeAnswers Share

0 Answer3 Likes